指南与共识妇科产科

遗传性癌症综合征与风险评估:ACOG委员会意见第793号摘要

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
指南 / 共识 · Obstet Gynecol · 2019-01-01

遗传性癌症综合征由基因致病性变异引起,常表现为早发癌症和常染色体显性遗传。妇产科医生应定期进行遗传性癌症风险评估,识别高危患者及家族,必要时转诊至癌症遗传学专家进行基因检测和个体化筛查或降低风险措施。本次修订更新了遗传性乳腺癌和卵巢癌、级联检测及遗传学专家转诊相关内容。

要点

  • 妇产科医生应定期进行遗传性癌症风险评估,包括个人史、家族史、病理和影像报告等。
  • 风险评估提示遗传性癌症综合征风险增加时,推荐转诊至癌症遗传学专家或遗传学专业人员。
  • 基因检测前后咨询是重要环节,讨论检测理由、披露结果、明确其他癌症风险并确保必要转诊。

核心结论

  • 遗传性癌症风险评估是识别癌症高风险患者和家族的关键,应由妇产科医生或其他妇产科保健提供者定期进行。
  • 风险评估提示遗传性癌症综合征风险增加时,推荐转诊至癌症遗传学专家或具有遗传学专长的医疗保健提供者,以扩展家族史信息收集、风险评估、教育和咨询,可能导向基因检测和个体化癌症筛查或降低风险措施,或两者兼有。

研究设计与样本

  • 美国妇产科医师学会(ACOG)委员会意见第793号,基于专家意见制定。

主要发现

  • 遗传性癌症综合征是某些类型癌症的遗传易感性,常早发,由一或多个基因的遗传性致病性变异引起,大多数呈常染色体显性遗传。
  • 与女性癌症相关的最常见遗传性癌症综合征包括遗传性乳腺癌和卵巢癌综合征、Lynch综合征、Li-Fraumeni综合征、Cowden综合征、Peutz-Jeghers综合征和遗传性弥漫性胃癌。
  • 风险评估包括个人史和家族史信息,含病理、影像报告及其他癌症医学风险因素评估。
  • 若风险评估提示遗传性癌症综合征风险增加,推荐转诊至癌症遗传学专家或遗传学专长提供者进行扩展家族史收集、风险评估、教育和咨询。
  • 目前基因检测由个人史、家族史、系谱分析及某些情况下的风险模型指导,风险模型可能包括病理报告和用医疗记录、死亡证明或两者确认癌症诊断。

关键数值与推荐

  • 推荐由妇产科医生或其他妇产科保健提供者进行遗传性癌症风险评估,并定期更新。
  • 风险评估提示遗传性癌症综合征风险增加时,推荐转诊至癌症遗传学专家或具有遗传学专长的医疗保健提供者。
  • 基因检测前后咨询应讨论检测理由、披露结果、明确其他癌症风险、识别教育需求并确保必要转诊。

临床怎么用

  • 妇产科医生或其他妇产科保健提供者应进行并定期更新遗传性癌症风险评估,包括个人史、家族史、病理和影像报告等。
  • 风险评估提示遗传性癌症综合征风险增加时,推荐转诊至癌症遗传学专家或遗传学专长提供者。
  • 基因检测应基于个人史、家族史、系谱分析及某些情况下的风险模型,并确保检测前后咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheritance. The most common hereditary cancer syndromes related to women's cancer include hereditary breast and ovarian cancer syndrome, Lynch syndrome, Li-Fraumeni syndrome, Cowden syndrome, Peutz-Jeghers syndrome, and hereditary diffuse gastric cancer. A hereditary cancer risk assessment is the key to identifying patients and families who may be at increased risk of developing certain types of cancer. Assessments should be performed by obstetrician-gynecologists or other obstetric-gynecologic care providers and should be updated regularly. An assessment includes information on personal and family history, including pathology, imaging reports, and evaluation of other medical risk factors for cancer. If a hereditary cancer risk assessment suggests an increased risk of a hereditary cancer syndrome, referral to a specialist in cancer genetics or a health care provider with expertise in genetics is recommended for expanded gathering of family history information, risk assessment, education, and counseling, which may lead to genetic testing and tailored cancer screening or risk reduction measures, or both. Currently, genetic testing is guided by personal history, family history, pedigree analysis and, in some cases, risk models that may include pathology reports and confirmation of cancer diagnoses with medical records, death certificates, or both. Counseling before and after genetic testing is an important part of the process to discuss rationale for any genetic testing, disclose results, define other cancer risks, identify educational needs, and secure referrals if necessary for ongoing management. This revision includes updates related to hereditary breast and ovarian cancer, cascade testing, and referrals to genetics specialists.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793. Obstet Gynecol. 2019. PMID: 31764755. doi:10.1097/AOG.0000000000003563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。